Vertex Pharmaceuticals

Quality Senior Director, QP

Vertex Pharmaceuticals  •  Ireland (Remote)  •  4 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

The Senior Director, Qualified Person (QP) is the senior leadership position accountable for the strategic

direction, governance and operational effectiveness of the QP function. The role supports the clinical and

commercial product portfolio across assigned territories. The role builds and leads the QP organisation,

establishes the QP operating model and decision framework, and ensures medicinal products are

certified and released in accordance with applicable Marketing Authorisations, Manufacturing and

Importation Authorisations, Good Manufacturing Practice (GMP), Annex 16 and clinical trial

requirements.

The Senior Director provides independent, risk-based QP leadership across the product lifecycle; aligns

QP strategy with portfolio, launch, geographic expansion and patient-supply priorities; and serves as a

senior interface with regulatory authorities, Quality, CMC, Manufacturing, Supply Chain, Regulatory,

Clinical, Commercial, Patient Safety and external partners. As a member of the Distribution & Market

Quality leadership team, the role is accountable for organisational capability, talent, inspection readiness,

continuous improvement and sustained compliance across QP activities.

This position reports to: Executive Director, Distribution & Market Quality.

Key Duties and Responsibilities:

  • Serves as the senior leader for the QP function, with accountability for QP strategy, governance,organisational capability and compliant batch certification for clinical and commercial products.
  • Defines and executes a multi-year QP strategy and operating plan aligned with the business portfolio, product launches, clinical development, commercial supply, geographic expansion, patient-supply priorities and evolving regulatory expectations.
  • Builds, leads and develops a high-performing QP organisation through strategic workforce planning, succession planning, recruitment, capability development, workload and capacity planning, and effective deployment of internal and external QP resources.
  • Establishes clear QP governance, decision rights, escalation pathways and performance expectations, enabling consistent, timely and independent certification decisions across products,sites, modalities and jurisdictions.
  • Ensures each applicable batch is certified and released in accordance with the relevant Marketing Authorisation or clinical trial authorisation, Manufacturing and Importation Authorisation, GMP,Annex 16 and applicable national requirements.
  • Provides technical and strategic leadership for complex batch-certification matters, including deviations, out-of-specification results, changes, investigations, supply-chain risks and other information relevant to batch quality and compliance.
  • Maintains effective oversight of the Pharmaceutical Quality System supporting QP reliance,including authorised activities, quality records, technical and quality agreements, supply-chain maps, audit and inspection information, and ongoing assurance of manufacturing and testing sites.
  • Ensures Manufacturing and Importation Authorisations and associated licences accurately reflect current and planned organisational activities, and sponsors timely assessment and implementation of licence changes required by portfolio or network evolution.
  • Acts as a primary senior contact for regulatory authorities on QP certification and licence-relatedmatters; leads or supports inspections and regulatory interactions; and ensures robust preparation, response, remediation and sustained inspection readiness.
  • Chairs or represents the QP function in relevant governance forums, including the Global QP Governance Committee, and provides transparent escalation of material quality, compliance, release and patient-supply risks to senior Quality leadership.
  • Partners across Quality, CMC, Manufacturing, Supply Chain, Regulatory, Clinical, Commercial, Patient Safety and external organisations to embed QP requirements early in product, process,site, launch and market-entry strategies.
  • Provides strategic oversight of contract manufacturers, testing sites and external QP service providers, ensuring appropriate qualification, agreements, performance management, escalation and resolution of significant compliance issues.
  • Owns QP functional performance and management review, using meaningful metrics, trends and risk insights to monitor QMS effectiveness, certification performance, capacity, right-first-time execution and continuous improvement.
  • Champions standardisation, simplification, digital enablement and continuous improvement of QP processes while preserving each QP's independent legal and professional accountability.
  • Contributes to Distribution & Market Quality strategy, annual and long-range planning, budget and resource prioritisation, translating strategic objectives into measurable plans, accountabilities and outcomes.
  • Acts as delegate for the Head of Distribution & Market Quality when required and represents the function in senior cross-functional and external forums.

Knowledge and Skills:

In-depth knowledge of UK and EU GMP requirements, Annex 16 batch-certification principles,

Marketing Authorisation and clinical-trial requirements, MIA licensing and current regulatory

expectations.

  • Demonstrated ability to make independent, legally accountable and risk-based certification

decisions in complex clinical and commercial supply environments.

  • Proven leadership ability to design and evolve functional strategy, governance and operating

models, and translate strategy into measurable objectives, resources and execution plans.

  • Expert ability to collaborate and influence across all levels of the organisation, present persuasive

recommendations, constructively challenge, build consensus and resolve complex cross functional

issues.

  • Strong understanding of quality risk management, including ICH Q9, and continuous improvement

principles, including ICH Q10, applied across the Pharmaceutical Quality System and product

lifecycle.

  • Broad technical understanding of pharmaceutical manufacturing, testing, packaging and supply

chains; experience with complex modalities, including cell and gene therapy, is desirable.

  • Strong analytical, critical-thinking and decision-making skills, with the ability to anticipate

challenges, evaluate competing quality and supply considerations, and escalate material risks

appropriately.

  • Financial and organisational acumen, including long-range planning, budget and resource

management, external-service strategy and change leadership.

  • Excellent written and verbal communication skills and proficiency with standard Microsoft Office

Education and Experience:

  • Bachelor's degree in pharmacy, chemistry, biology or another relevant scientific discipline or equivalent experience.
  • Eligible to act as a Qualified Person in accordance with Article 51 of Directive 2001/83/EC and applicable EU requirements.
  • Extensive relevant pharmaceutical Quality experience, or an equivalent combination of education and experience, including significant experience performing QP duties and leading QP teams.
  • Previous experience named as a QP on a Manufacturing and Importation Authorisation is required.
  • Experience leading QP activities and teams across different jurisdictions, including strategic workforce, talent, succession and capability planning.• Demonstrated regulatory-authority interaction and inspection leadership, including negotiation and resolution of QP certification, compliance and licence-related matter.

At Vertex, we embrace continuous learning and encourage employees to stay informed on advances in AI, technology, automation, and industry trends. We seek talent who bring an external perspective, demonstrate curiosity and sound judgment, and thoughtfully adopt new capabilities that improve decision-making, drive innovation, increase efficiency, and help deliver better outcomes for patients.

Flex Designation:

Remote-Eligible

Flex Eligibility Status:

In this Remote-Eligible role, you can choose to be designated as:

  1. Remote: work remotely five days per week and come into the office on occasion – you’re always welcome on-site; or select
  2. Hybrid: work remotely up to two days per week; or select
  3. On-Site: work five days per week on-site with ad hoc flexibility.

Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.

#LI-Remote

Company Information

Vertex is a global biotechnology company that invests in scientific innovation.

Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at ApplicationAssistance@vrtx.com

Vertex Pharmaceuticals

About Vertex Pharmaceuticals

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.

Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide.

Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards.

Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/

Industry
Biotech & Life Sciences
Company Size
5,001-10,000 employees
Headquarters
Boston, MA
Year Founded
1989
Website
vrtx.com
Social Media